Alzheimer's

Alzheimer's

Alzheimer's

Reactions: ChatGPT algorithms could help identify Alzheimer's cases

Artificial intelligence algorithms using ChatGPT - the OpenAI company's GPT-3 language model - can identify speech features to predict the early stages of Alzheimer's disease with 80 per cent accuracy. The neurodegenerative disease causes a loss of the ability to express oneself that the algorithms could recognise, according to the journal PLOS Digital Health.

0

Reactions: data from Alzheimer's clinical trial with lecanemab antibody published

A few weeks ago, a press release from the Biogen and Eisai companies reported significant results from their lecanemab antibody for the treatment of early-stage Alzheimer's. The data from the phase 3 trial are now published in the New England Journal of Medicine, coinciding with the CTAD conference on Alzheimer's disease clinical trials in San Francisco. Data from the phase 3 clinical trial are now published in the New England Journal of Medicine, coinciding with the 15th CTAD Alzheimer's disease clinical trials conference in San Francisco.

0

Reaction to the study finding prion forms in the brains of people with dementia and Down syndrome

People with Down syndrome are at high risk of developing dementia very similar to that caused by Alzheimer's disease. A study published in the journal PNAS has found that in these people, as had been observed in "classic" Alzheimer's, the characteristic proteins of the disease have prion-like features.

0

Reaction to method that could predict Alzheimer's risk before symptoms appear

Scientists have analysed data on 7.1 million common DNA variants (alterations in the standard sequence) in people with and without Alzheimer's disease. The results, published in PLOS Genetics, have helped them to develop a method that can predict the risk of suffering from this neurodegenerative disease, depending on the DNA variants that a person has and before presenting symptoms.